Debiopharm reveals phase 1/2 GaLuCi research results
24th March 2023 Uncategorised 0The multi-centre international clinical trial will evaluate company’s Debio 0328 candidate
More: Debiopharm reveals phase 1/2 GaLuCi research results
Source: News
The multi-centre international clinical trial will evaluate company’s Debio 0328 candidate
More: Debiopharm reveals phase 1/2 GaLuCi research results
Source: News
© 1994 - 2026 B.M. Pharmaceuticals